Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer

Jeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al. · 2009

Read Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer by Jeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004455.txt.

Description

Blocking a survival protein made pancreatic tumors less invasive in mice, report Jeffrey Hager, Danielle Ulanet, Lothar Hennighausen, and co-authors in PLOS ONE in 2009. Cells die by a built-in program that members of the Bcl-2 family control. Tumors often raise the levels of family members that block death, which helps them survive.

The protein studied here is Bcl-x, one of those death blockers. The team removed it genetically in a mouse model of pancreatic neuroendocrine cancer. Surprisingly, tumor growth and cell death barely changed, but the tumors became much less invasive, as the title reports. That split result matters: a drug target need not shrink a tumor to be useful if it stops the tumor from spreading into new tissue.

Catalog record

CREATORJeffrey H. Hager, Danielle B. Ulanet, Lothar Hennighausen et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004455

Browse the full library · About the Tower of Babel